Find your path to BRIDGET
138 people in our graph share verified history with BRIDGET β schools, employers, funds. One of them is your warm intro.
Santiago ReganunlockedBRIDGET: together at Brandeis University
Γ9BRIDGET: together at Brandeis University
Γ2BRIDGET: together at Surface Logix Inc
Executive at Nocion Therapeutics
Intro paths
β
In turn, BRIDGET can intro founders to Nocion Therapeutics's investors below.
Nocion Therapeutics's investors Β· 6
Canaan PartnersStamford Β· $500K β $20M checks Β· since 2025F-Prime CapitalCambridge Β· $3M β $10M checks Β· since 2024Mission BiocapitalSan Francisco Β· $500K checks Β· since 2024Monograph Capital PartnersLondon Β· since 2025Osage University PartnersBala Cynwyd Β· since 2024OUP (Osage University Partners)Bala Cynwyd Β· $1M β $20M checks
Experience
- Retension PharmaceuticalsScientific Advisor and CMC Consultantcurrent2025 β present
- Response PharmaceuticalsScientific Advisor and CMC Consultantcurrent2025 β present
- 1910 GeneticsChief Scientific Officer2023 β 2025Boston, Massachusetts, United States
- 1910 GeneticsSenior Vice President & Head of Chemistry2023Boston, Massachusetts, United States
- Nocion Therapeutics, Inc.Senior Vice President & Head of Chemistry2020 β 2023Waltham, Massachusetts, United States
- Nocion Therapeutics, Inc.Vice President & Head of Chemistry2018 β 2019Cambridge, MA
- Axial Biotherapeutics, Inc.Vice President of Chemistry2017 β 2018Greater Boston Area
- Flatley Discovery LabVice President of Drug Discovery2016 β 2017
- Flatley Discovery LabVice President of R&D Chemistry2014 β 2015Charlestown, MA
- Flatley Discovery LabDirector of Medicinal Chemistry2011 β 2014
- Surface LogixVice President of Discovery Research2008 β 2011
- Surface Logix IncVice President of Medicinal Chemistry2006 β 2008
- ASDISAB2009 β 2010
- PfizerAssociate Director of Chemistry2004 β 2006
- PfizerSenior Principal Scientist2001 β 2004
- PfizerProject Leader2000 β 2001
- PfizerSenior Research Scientist2000
- PfizerResearch Scientist1997 β 2000
Skills & more
Medicinal ChemistryProject ManagementToxicokineticsDrug DiscoveryPharmacokineticsINDValidationADMEAssay DevelopmentOncologyClinical DevelopmentBiotechnology
+11 more
In VitroIn VivoLifesciencesDrug DevelopmentPharmaceutical IndustryOrganic ChemistryLife SciencesChemistryDrug DesignLead ChangeCROFrom BRIDGET's professional profile.
Frequently asked questions
- Who is BRIDGET M. COLE?
- Executive Officer at Nocion Therapeutics
- Where does BRIDGET M. COLE work?
- BRIDGET M. COLE is Executive at Nocion Therapeutics.
- Where did BRIDGET M. COLE go to school?
- BRIDGET M. COLE studied at Brandeis University (Ph.D., Chemistry); Boston College (Postdoctoral Research Fellow, Chemistry); Boston University (Bachelor's degree, Chemistry).
Same school
Also attended Brandeis University142
Santiago ReganDirector of Business Development at Redpoint VenturesNicholas AdamsManaging Partner at Differential VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesSeth LieblichInvestment Team at 8VCAlex MorganInvestor at Khosla Ventures
+ 136 more
Also attended Boston College451
Pat GradyPartner at Sequoia CapitalDavid FialkowVenture capitalist and Academy Award-winning documentary filmmaker who co-founded General CatalystNicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Bijan SabetPersonal journalSteve MurrayAdvisor, Revolution Growth at RevolutionNatalie SchmitkeManaging Director Capital Networks at Burda Principal Investments
+ 445 more
Shared employers
Also worked at Retension Pharmaceuticals2
Also worked at Response Pharmaceuticals2
Also worked at Nocion Therapeutics, Inc.4
Also worked at Axial Biotherapeutics, Inc.7
Sarah MeibuschPartner at OneVenturesDavid ParkExecutive in Residence at Kairos Venture Investments, LlcEric De La FortelleManaging Partner at Cathay HealthSrinivas RaoCo-Founder and Chief Executive Officer at atai Life SciencesGlenn ShortChief Scientific Officer at atai Life SciencesRyan BarrettChief Legal and Business Officer at AtaiBeckley
+ 1 more



































